Showing results (111-120 of 896) with videos related to

Sort By:
Pageof 90
International Journal of Sports Physiology and Performance|April 16, 2020
A Systematic Review of the External and Internal Workloads Experienced During Games-Based Drills in Basketball PlayersCody J O'Grady, Jordan L Fox, Vincent J Dalbo, et al.
Gerodontology|October 18, 2015
Does residential aged care need dental professionals? A qualitative study on dental professionals' perceptions in AustraliaKatherine F Britton, Angela Durey, Martin J O'Grady, et al.
Digestive Diseases and Sciences|March 31, 2021
Acute Diverticulitis in Young Patients: A Review of the Changing Epidemiology and EtiologyGreg A Turner, Michael J O'Grady, Rachel V Purcell, et al.
Current Protocols in Stem Cell Biology|November 23, 2019
Spatiotemporal Control of Morphogen Delivery to Pattern Stem Cell Differentiation in Three-Dimensional HydrogelsBrian J O'Grady, Daniel A Balikov, Ethan S Lippmann, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamoleH Pickles, A Fish, S Hassan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1989
Beneficial effect of long-term PGE1-treatment in left ventricular heart failureI Virgolini, J Kaliman, P Fitscha, et al.
Prostaglandins|June 1, 1987
Prostaglandin I2 reduces activation of human arterial smooth muscle cells in-vivoH Sinzinger, T Zidek, P Fitscha, et al.
Hepatology (Baltimore, Md.)|March 1, 1986
Late onset hepatic failure: clinical, serological and histological featuresA E Gimson, J O'Grady, R J Ede, et al.
British Journal of Clinical Pharmacology|September 1, 1982
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in manS Hassan, H Pickles, A Fish, et al.
Pageof 90